Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Watch a 57-minute keynote presentation from Dr. Chalabi, a Gastrointestinal Oncologist and clinician scientist from the Netherlands Cancer Institute, as she discusses groundbreaking research on early innovative combination immunotherapy trials for colorectal cancer. Explore the evolution of immunotherapy, its mechanisms, and response determinants while learning about different types of colorectal cancer, including MMR proficient and MMR deficient cases. Gain insights into early-stage colon cancer treatment, the NICHE study design, treatment tolerance, and response evaluation. Understand the future prospects of immunotherapy for colorectal cancer and the goals researchers aim to achieve in this field. Delivered at the Young-Onset Colorectal Cancer Center's fourth annual Patient and Family Forum at Dana-Farber Cancer Institute, this comprehensive presentation combines clinical expertise with cutting-edge translational research to advance understanding of tumor response drivers and novel immunotherapy treatments.
